| abstract |
The invention relates to a thermoformed pharmaceutical dosage form having a breaking strength of at least 300N, said dosage form comprising an opioid (A), a free physiologically acceptable acid (B) in an amount of from 0.001 to 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form, and a polyalkylene oxide (C) having a weight average molecular weight Mw of at least 200,000 g/mol. |